Federal Joint Committee
12
1
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Dyadic, App-supported Collaborative Care Intervention Trial for Family Caregivers of People Living With Dementia
Role: collaborator
Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
Role: collaborator
Primary Hormone-sensitive Breast Cancer: Need-driven Health Care Improvement by Patient-centred Digital Application
Role: collaborator
Interprofessional Dementia Care
Role: collaborator
Family Health Partners in Regional Network Structures
Role: collaborator
Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation
Role: collaborator
Enhancing the Clinical Effectiveness of Depression Screening Using Patient-targeted Feedback in General Practices
Role: collaborator
Evaluation of an Interactive Risk Information Tool to Increase COVID-19 Vaccination Incidence in Vaccine-hesitant People
Role: collaborator
Dialysis Training Therapy: The DiaTT Trial
Role: collaborator
Early Detection and Early Intervention Program in High-risk Patients to Avoid Invasive Long-term Ventilation
Role: collaborator
Lifestyle Intervention in Chronic Ischemic Heart Disease and Diabetes
Role: collaborator
Improvement of Transition From Hospital to Home for Older Patients in Germany
Role: collaborator
All 12 trials loaded